Picard Medical Inc PMI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $4.41
- Day Range
- $4.55–5.33
- 52-Week Range
- $2.65–684.00
- Bid/Ask
- $5.77 / $5.90
- Shares Outstanding
- 2.34M
- Market Cap
- $10.95M
- Volume/Avg
- 58,719 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 75
- Website
- https://www.picardmedical.com
Valuation
|
Metric
|
PMI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.38 |
Price/Sales | 0.61 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PMI
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 1.02 |
Interest Coverage | −10.17 |
Quick Ratio
PMI
Profitability
|
Metric
|
PMI
|
|---|---|
Return on Assets (Normalized) | −113.82% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −540.35% |
Return on Assets
PMI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|S@wlMGB | LOCK|nv$# | $176B | |||
| Medtronic PLC
MDT
| LOCK|!><qMB | LOCK|<?#c^ | $116B | |||
| Stryker Corp
SYK
| LOCK|TkclVhLP | LOCK|dJ? | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|&^$Nz<# | LOCK|&m^r$ | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|V^&$hW$H | LOCK|%?QT> | $49B | |||
| DexCom Inc
DXCM
| LOCK|t$V^!%@< | LOCK|cTn<Y | $31B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Pct$@M | LOCK|lt | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|z#% | LOCK|rf$ | $24B | |||
| Steris PLC
STE
| LOCK|SP!$^Z% | LOCK|$@r< | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|HswV<R$ | LOCK|CD$ | $18B |
United States